id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-1429-0016,FDA,FDA-2013-N-1429,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry on Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of Federal Food, Drug, and Cosmetic Act",Notice,30 Day Proposed Information Collection,2017-10-16T04:00:00Z,2017,10,2017-10-16T04:00:00Z,2017-11-16T04:59:59Z,2017-10-16T15:26:21Z,2017-22284,0,0,0900006482bcdf2f
FDA-2013-N-1429-0015,FDA,FDA-2013-N-1429,"Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act",Notice,60 Day Proposed Information Collection,2017-06-20T04:00:00Z,2017,6,2017-06-20T04:00:00Z,2017-08-22T03:59:59Z,2017-06-20T13:34:42Z,2017-12838,0,0,09000064826f5c30